Where does Miltenyi Biotec, Inc. rank among US patent assignees?

According to USPTO PatentsView (2015–2025 granted utility patents), Miltenyi Biotec, Inc. ranks #8,249 of 49,997 assignees by granted-patent volume, the same sort as the companies listing and top-holders ranking. See /methodology/#corpus-placement.

How many patents does Miltenyi Biotec, Inc. hold?

Miltenyi Biotec, Inc. holds 39 US utility patents granted between 2015 and 2023, spanning 19 technology areas.

What is Miltenyi Biotec, Inc.'s Innovation Score?

Miltenyi Biotec, Inc. has an Innovation Score of 37.1 out of 100 (top 44% of the corpus). This composite metric weighs portfolio volume (40%), grant velocity (20%), technology breadth (25%), and claim depth (15%).

Is Miltenyi Biotec, Inc.'s patent grant rate increasing or decreasing?

Miltenyi Biotec, Inc.'s recent grant velocity is -82% compared to the prior five-year period (grant years, not application filing dates). Grant activity has slowed relative to earlier years.

What does claim depth mean for Miltenyi Biotec, Inc.'s patents?

Miltenyi Biotec, Inc.'s patents average 11.9 claims each. This is an aggregate descriptive count from the grant record; it does not establish claim scope, legal strength, enforceability, or design-around risk.

How is the Miltenyi Biotec, Inc. patent data sourced?

All patent data comes from USPTO PatentsView, a public research dataset maintained by the United States Patent and Trademark Office covering US granted utility patents from 2015 to 2025.

USPTO 2015–2025 USPTO PatentsView US Corporation

Miltenyi Biotec, Inc.

Q: What technology areas does Miltenyi Biotec, Inc. focus on?

Miltenyi Biotec, Inc.'s top technology area is C12N (Microorganisms OR ENZYMES; Compositions THEREOF; Propagating, Preserving, OR Maintaining MICROORGANISMS; Mutation OR Genetic ENGINEERING; Culture Media) with 23 patents, ranking #461 of 4,144 assignees active in that subclass. Grants appear in 19 CPC subclasses total.

USPTO PatentsView assignee record - 39 granted patents across 19 technology areas, recorded in grant years 2015–2023. Grant-trend analysis is cross-referenced to USPTO Patent Public Search; it does not measure application filings, current R&D, or legal strength. Primary class: C12N (Microorganisms OR ENZYMES; Compositions THEREOF; Propagating, Preserving, OR Maintaining MICROORGANISMS; Mutation OR Genetic ENGINEERING; Culture Media).

Compiled by PlainPatent · May 15, 2026

RSS updates for this company

Explore the portfolio See the ranking

The verdict

According to USPTO PatentsView, Miltenyi ranks #8,249 of 49,997 tracked US assignees by granted-patent volume, with 39 patents across 19 technology areas.

#8,249
of 49,997 US assignees by volume: Top 44%
by Innovation Score (37.1/100): 11.9
avg claims per patent: -82%
grant velocity, last 5 yrs

USPTO PatentsView assignee plate

Corpus R8249 · US Corporation #8,249 · 39 grants

GRANTS-SMALL · UPPER-Q · PHOTO-FINISH · CPC-FOCUS · INNOV-THIN · CLAIMS-PAR · TYPE-USCORP · VEL-DROP · BOOK-FULL

GRANTS-SMALL 39 grants
UPPER-Q #8,249/49,997
PHOTO-FINISH Lungpacer Medical
CPC-FOCUS C12N · 19 areas
INNOV-THIN 37.1/100
CLAIMS-PAR 11.9 claims/avg
TYPE-USCORP US Corporation
VEL-DROP -82% vel
BOOK-FULL 10/10 fields

Nearest grant-volume peer: Lungpacer Medical Inc. (±0 grants)

Instrument codes from this assignee’s USPTO PatentsView grant sheet: volume band, corpus rank, photo-finish peer, lead CPC, Innovation Score, claim depth, assignee type, velocity, and book completeness. Not a USPTO rating of patent strength.

How Miltenyi’s 37.1 Innovation Score adds up

The same four weighted components behind every Innovation Score on PlainPatent: portfolio volume, grant velocity, technology breadth, and claim depth.

Volume 12.7 pts (34%) Velocity 1.8 pts (5%) Breadth 15.4 pts (42%) Claim depth 7.2 pts (19%)

Qualcomm Incorporated · highest

85
Miltenyi Biotec · this assignee

37
Modernsolid Industrial · near

37
Oncotherapy Science · near

37
TYR Tactical · near

37
Kawai Gakki Seisakusho · near

37
3D Lighting… · lowest

7

What this shows Miltenyi's Innovation Score is 37.1/100 (top 44% of the PatentsView-derived corpus). The chart places that score against the nearest Innovation Score peers plus corpus poles, not a reprint of the volume ranking.

Does more volume mean deeper claims for Miltenyi?

Each dot is one of Miltenyi’s 8 nearest volume peers (same corpus rank neighbourhood as the chart above), placed by total granted patents (horizontal) against average claims per patent (vertical). Miltenyi’s own 11.9 claims/patent is at or below the 16.8 median for these volume peers. Volume here does not track with deeper claims; several lower-volume peers claim more thoroughly per patent.

Miltenyi vs its 8 nearest volume peers: granted patents vs average claims per patent. Source: USPTO PatentsView.

Where Miltenyi's grants concentrate

Miltenyi Biotec, Inc. is a focused PatentsView assignee: 19 CPC subclasses with 59% of grants classified under C12N (Microorganisms OR ENZYMES; Compositions THEREOF; Propagating, Preserving, OR Maintaining MICROORGANISMS; Mutation OR Genetic ENGINEERING; Culture Media). Peak complete grant year is 2018 (11 grants) versus a trough of 1 in 2023. By volume, Miltenyi sits between Lungpacer Medical Inc. and MyFitnessPal, Inc..

Miltenyi's three-year grant acceleration

Miltenyi Biotec, Inc. shows 3 grants in 2022–2024 against only 11 in 2019–2021. That prior window is too thin for a growth multiple (rename and spin-out assignees look artificially high when the baseline is near zero), so PlainPatent withholds a ranked acceleration claim here.

Lungpacer Medical

39
Luxvue Technology

39
Meijo University

39
Mercari

39
Mitchell Internat…

39
Mitsubishi Shindoh

39
Moximed

39
Myfitnesspal

39
Miltenyi Biotec ◀

39

What this shows Miltenyi holds 39 patents at rank #8,248, shown against the 8 assignees closest to it in grant volume rather than the industry's largest filers.

Companies ranked near Miltenyi

By rank, the assignees closest to #8,248 in granted patent volume.

Leaders in C12N (Microorganisms OR Enzymes)

Other assignees with the most granted patents in Miltenyi's primary technology class.

Assignees with similar portfolio profiles

Two PlainPatent-derived peer sets for Miltenyi, neither rank-band nor same-CPC leaders (those blocks stay above). In C12N (Microorganisms OR Enzymes), Miltenyi ranks #461 of 4,144 assignees by patent count in that subclass.

Similar innovation score

Nearest assignees by Innovation Score (37 here).

Modernsolid Industrial Co., Ltd. 37 Oncotherapy Science, Inc. 37 TYR Tactical, LLC 37 Kabushiki Kaisha Kawai Gakki Seisakusho 37

Miltenyi's Innovation Score vs. every tracked assignee

Composite of portfolio volume, grant velocity, technology breadth, and claim depth (0–100)

37 Top 44% higher than 56% of 49,997 US assignees

Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.

Source USPTO PatentsView, PlainPatent Innovation Score · 2015–2025

USPTO utility patent grants by year · 2015–2023

Grants by year

Teal-shaded recent years (2020–present) versus the 2015–2019 baseline. Full figures in the table below.

View data table

Miltenyi Biotec, Inc. patent grants by year, 2015–2025
Year	Patents Granted	Share of Period
2015	3	7.7%
2016	2	5.1%
2017	9	23.1%
2018	11	28.2%
2019	8	20.5%
2021	3	7.7%
2022	2	5.1%
2023	1	2.6%

Which technologies does Miltenyi Biotec, Inc. patent most?

C12N - Microorganisms OR ENZYMES; Compositions THEREOF; Propagating, Preserving, OR Maintaining MICROORGANISMS; Mutation OR Genetic ENGINEERING; Culture Media 23

G01N - Investigating OR Analysing Materials BY Determining Their Chemical OR Physical Properties 22

A61K - Preparations FOR Medical, Dental OR Toiletry Purposes 16

C12M - Apparatus FOR Enzymology OR MICROBIOLOGY; Apparatus FOR Culturing Microorganisms FOR Producing Biomass, FOR Growing Cells OR FOR Obtaining Fermentation OR Metabolic Products, i.e. Bioreactors OR Fermenters 13

B01L - Chemical OR Physical Laboratory Apparatus FOR General USE 8

C07K - Peptides 8

B04B - Centrifuges 6

B01D - Separation 6

B03C - Magnetic OR Electrostatic Separation OF Solid Materials From Solid Materials OR FLUIDS; Separation BY High-voltage Electric Fields 6

A61P - Specific Therapeutic Activity OF Chemical Compounds OR Medicinal Preparations 5

A61M - Devices FOR Introducing Media Into, OR Onto, THE Body ; Devices FOR Transducing Body Media OR FOR Taking Media From THE Body ; Devices FOR Producing OR Ending Sleep OR Stupor 5

B01F - Mixing, e.g. Dissolving, Emulsifying OR Dispersing 2

C09B - Organic Dyes OR Closely-related Compounds FOR Producing Dyes ; , e.g. PIGMENTS; MORDANTS; Lakes 2

G16B - Bioinformatics, i.e. Information AND Communication Technology [ICT] Specially Adapted FOR Genetic OR Protein-related Data Processing IN Computational Molecular Biology 2

C08G - Macromolecular Compounds Obtained Otherwise Than BY Reactions Only Involving Unsaturated Carbon-to-carbon Bonds 1

Top 15 of 19 technology areas

More on this record

Data Source

USPTO PatentsView, US granted patents 2015–2025

View all rankings → How is Innovation Score calculated?

What to do with this data

Miltenyi Biotec, Inc.'s patent record in context - here's where to go next.

Miltenyi Biotec, Inc.'s lead technology class is C12N (Microorganisms OR ENZYMES; Compositions THEREOF; Propagating, Preserving, OR Maintaining MICROORGANISMS; Mutation OR Genetic ENGINEERING; Culture Media), 59% of its portfolio - see every assignee active in that class. Explore C12N
Ranked #8,249 of 49,997 tracked assignees by patent volume - see the full leaderboard. See the ranking
Compare Miltenyi Biotec, Inc. against Lungpacer Medical Inc., an assignee filing at a similar volume. Compare portfolios
Innovation Score of 37.1/100 blends volume, velocity, technology breadth, and claim depth. How it's calculated

Figures reflect USPTO PatentsView grant data through May 2026; pending applications not yet granted are not counted.

Data sourced from USPTO PatentsView - official U.S. government patent data. See our methodology for computation details. Retrieved and formatted by PlainPatent

Disclaimer: This information is provided for informational purposes only and does not constitute professional advice. Data is sourced from the USPTO PatentsView database. Consult a qualified professional before making decisions based on this data.

Read our methodology - how this data is sourced, computed, and verified.

Data sources used on this page

USPTO PatentsView - the disambiguated bulk patent-grant, assignee, and CPC data this page's figures are derived from. patentsview.org
Cooperative Patent Classification (CPC) - the joint USPTO/EPO classification scheme used to group patents by technology area. cooperativepatentclassification.org
USPTO Patent Public Search - the official interface to verify the status of any individual patent. ppubs.uspto.gov

Compiled by PlainPatent, US Patent Intelligence Editorial Process · May 15, 2026

Every figure on PlainPatent is rendered directly from USPTO source data, no number is typed in by an editor. This page draws directly on USPTO source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.